首页> 外文期刊>风湿病与自身免疫疾病期刊(英文) >Long-Term Oral Corticosteroid-Therapy: Description of the Practice of Adjuvant Measures by Dakar Medical Specialists
【24h】

Long-Term Oral Corticosteroid-Therapy: Description of the Practice of Adjuvant Measures by Dakar Medical Specialists

机译:长期口服皮质类固醇疗法:达喀尔医学专家对辅助措施实践的描述

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The extended administration of corticoids by oral way for a length of more than 3 months defines the long-term-corticosteroid-therapy. This one, used in numerous indications, displays most often at the risk of undesirable effects linked sometimes to the habits of prescription of the doctors. Patients and Methods: In order to study the prescription modalities of this treatment, we conducted a cross-sectional, multicentric and descriptive study from June 1st, 2017 to August 1st, 2017, over a period of 2 months. It involved a questionnaire given to medical specialists of all medical specialties and practicing in the University Hospital of Dakar. Results: 170 doctors were interviewed. Dermatologists and internists were mostly found 19.4% and 18.8% or 33% and 34% doctors. Systemic autoimmune diseases alone accounted for 48% of prescription reasons. Prednisone was prescribed in 88% of cases. The immunosuppressive dose of 1 mg/kg was most often prescribed. Practitioners very heterogeneously prescribe most adjuvant measures to prolonged systemic corticosteroid therapy. Thus, the recommendation of a low-sodium diet (38% of physicians), and the systematic prescriptions of proton pump inhibitors (44.7% of physicians) and vitamin-calcium supplementation were frequently performed by physicians (34% of physicians). While the low carbohydrate diet was advocated by less than a quarter of doctors and the prevention of pneumocystosis and osteoporosis were rare (respectively 61% and 52% of prescribers did not). Conclusion: The global analysis of the habits of our medical specialists concerning the use of long-term glucocorticoids reflected a diversity of indications, heterogeneity of practices, with certain habits not in accordance with the usual recommendations.
机译:简介:通过口服延长皮质醇的延长施用超过3个月的长度定义了长期皮质类固醇治疗。在众多指示中使用的这一点最常见于有时与医生处方的处方习惯相关的不良影响的风险。患者和方法:为了研究这种治疗的处方方式,我们从2017年6月1日至2017年8月1日在2个月内进行了一项横截面,多中心和描述性研究。它涉及给达喀尔大学医院医学专家提供的调查问卷。结果:170名医生接受了采访。皮肤科医生和内科医生主要被发现19.4%和18.8%或33%和34%的医生。单独的系统性自身免疫疾病占处方原因的48%。泼尼松在88%的病例中规定。 1mg / kg的免疫抑制剂量通常是规定的。从业者非常异质地规定大多数佐剂措施,以长期全身性皮质类固醇治疗。因此,医生(34%的医生)经常进行低钠饮食(38%的医生)和质子泵抑制剂的系统处方(44.7%)和维生素钙补充剂的建议。虽然低于四分之一的医生提倡低碳水化合物饮食,但预防肺炎和骨质疏松症是罕见的(分别为61%和52%的处方没有)。结论:全球关于使用长期糖皮质激素的医学专家习惯的全球分析反映了迹象的多样性,实践的异质性,某些习惯不按照通常的建议。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号